Minimally Invasive Surfactant Administration: From LISA to Aerosol to SALSA

Only available as part of a package

Explore the evolving landscape of surfactant delivery with a focus on patient-centered care. This session introduces three minimally invasive techniques—LISA (Less Invasive Surfactant Administration), aerosolized surfactant, and SALSA (Surfactant Administration through Laryngeal or Supraglottic Airways)—through engaging video demonstrations and expert-led discussion. Led by an internationally experienced educator and current study chair on aerosol delivery, this session equips clinicians with the knowledge and skills to tailor surfactant administration to individual patient needs and prepare for the future of neonatal respiratory care.

Learning Outcomes:
Review and compare the current methods to deliver surfactant in a minimally invasive way: LISA, aerosol, and SALSA.
Identify which techniques might be best for the needs of your patients.
Obtain the skills needed through videos and a discussion of the techniques so minimally invasive surfactant administration can be implemented in your practice.

CE Credit Information:

Participants can earn 1 CE credit for viewing the presentation and completing the evaluation.

The National Association of Neonatal Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Scott Guthrie, MD, FAAP

Professor of Clinical Pediatrics

Scott Guthrie, MD, is a Professor of Clinical Pediatrics in the Division of Neonatology at the Vanderbilt University School of Medicine. He primarily works at the Vanderbilt NICU in the Jackson-Madison County General Hospital in Jackson, TN where he also serves as the Chair of Pediatrics. He is the previous Infant Medical Director for the Tennessee Initiative for Perinatal Quality Care and currently leads the Tennessee’s Tiniest Babies project. He is passionate about global health and is a US State Department Fulbright Scholar Specialist. This has allowed him to travel extensively to teach neonatology and help improve care for babies around the world. He is also active in clinical research and has co-authored articles on minimally invasive delivery of surfactant, delayed cord clamping, bronchopulmonary dysplasia, necrotizing enterocolitis, neonatal ventilation, and sepsis.

A relevant financial relationship with an ineligible company was identified for Scott Guthrie, who is a consultant for ONY Biotech. The relevant financial relationship(s) listed for this individual have been mitigated. The individual is to attest that clinical recommendations are evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines). Scott Guthrie is also a consultant at Infant Bacterial Therapeutics. No relevant financial relationship exists with disclosed ineligible company(s) and mitigation is not needed. The content of the activity is not related to the business lines or products of the individual's disclosed ineligible company.